These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 38504249)

  • 41. The Impact of Breathing Hypoxic Gas and Oxygen on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension.
    Carta AF; Lichtblau M; Berlier C; Saxer S; Schneider SR; Schwarz EI; Furian M; Bloch KE; Ulrich S
    Front Med (Lausanne); 2022; 9():791423. PubMed ID: 35223898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical Implications.
    Kularatne M; Gerges C; Jevnikar M; Humbert M; Montani D
    J Cardiovasc Dev Dis; 2024 Feb; 11(3):. PubMed ID: 38535101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
    Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analysis of high risk factors for patient death and its clinical characteristics on pregnancy associated with pulmonary arterial hypertension].
    Bao Z; Zhang J; Yang D; Xu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):495-500. PubMed ID: 25327730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scurvy-induced pulmonary arterial hypertension.
    Azar J; Ayyad M; Jaber Y; Ayasa LA
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37011995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
    Sato T; Furukawa T; Teramachi R; Fukihara J; Yamano Y; Yokoyama T; Matsuda T; Kataoka K; Kimura T; Sakamoto K; Ishii M; Kondoh Y
    Thorax; 2024 Apr; 79(5):422-429. PubMed ID: 38316550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis.
    Elkhapery A; Hammami MB; Sulica R; Boppana H; Abdalla Z; Iyer C; Taifour H; Niu C; Deshwal H
    J Cardiovasc Dev Dis; 2023 Dec; 10(12):. PubMed ID: 38132665
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of the Incidence of Chronic Thromboembolic Pulmonary Hypertension 1 Year After First Episode of Acute Pulmonary Embolism: A Cohort Study.
    Rashidi F; Parvizi R; Bilejani E; Mahmoodian B; Rahimi F; Koohi A
    Lung; 2020 Feb; 198(1):59-64. PubMed ID: 31894412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure.
    Lanzarini L; Fontana A; Campana C; Klersy C
    J Heart Lung Transplant; 2005 Jun; 24(6):745-54. PubMed ID: 15949736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure.
    Tsuchida K; Yamada H; Yamasaki Y; Suzuki K; Kongoji K; Akashi Y; Ozaki S
    Mod Rheumatol; 2015 Sep; 25(5):744-7. PubMed ID: 25736353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
    Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
    Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].
    Fan Y; Guo X; Sun X; Cao X; He J; Zhu L; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):972-977. PubMed ID: 31537222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the revised hemodynamic definition on the diagnosis of precapillary pulmonary hypertension: a retrospective single-center study in China.
    Jin Q; Zhang Y; Zhao Z; Zhao Q; Yu X; Yan L; Li X; Duan A; An C; Ma X; Xiong C; Luo Q; Liu Z
    Cardiovasc Diagn Ther; 2021 Oct; 11(5):1047-1057. PubMed ID: 34815955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation.
    Bundgaard H; Boesgaard S; Mortensen SA; Arendrup H; Aldershvile J
    Scand Cardiovasc J; 1997; 31(6):339-42. PubMed ID: 9455782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension.
    Corte TJ; Wort SJ; Gatzoulis MA; Macdonald P; Hansell DM; Wells AU
    Thorax; 2009 Oct; 64(10):883-8. PubMed ID: 19546096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular and Parenchymal Enhancement Assessment by Dual-Phase Dual-Energy CT in the Diagnostic Investigation of Pulmonary Hypertension.
    Bacon JL; Madden BP; Gissane C; Sayer C; Sheard S; Vlahos I
    Radiol Cardiothorac Imaging; 2020 Dec; 2(6):e200009. PubMed ID: 33778636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical characteristics of patients with chronic thromboembolic pulmonary hypertension].
    Xie WM; Wang J; Zhang S; Wan J; Tao XC; Gao Q; Zhai ZG; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(44):3461-3465. PubMed ID: 31826562
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP).
    Jerjes-Sánchez C; Ramírez-Rivera A; Hernandez NZ; Cueto Robledo G; García-Aguilar H; Gutiérrez-Fajardo P; Seoane García de León M; Moreno Hoyos-Abril F; Ernesto Beltrán Gámez M; Elizalde J; Fccp TP; Sandoval J;
    Pulm Circ; 2024 Apr; 14(2):e12395. PubMed ID: 38887742
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.